Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EUDA Health Holdings (EUDA) Liabilities and Shareholders Equity (2021 - 2023)

Historic Liabilities and Shareholders Equity for Health Holdings (EUDA) over the last 3 years, with Q2 2023 value amounting to $2.1 million.

  • Health Holdings' Liabilities and Shareholders Equity changed N/A to $2.1 million in Q2 2023 from the same period last year, while for Dec 2024 it was $2.1 million, marking a year-over-year decrease of 9609.26%. This contributed to the annual value of $25.6 million for FY2022, which is 22040.19% up from last year.
  • As of Q2 2023, Health Holdings' Liabilities and Shareholders Equity stood at $2.1 million.
  • In the past 5 years, Health Holdings' Liabilities and Shareholders Equity ranged from a high of $25.6 million in Q4 2022 and a low of $2.1 million during Q2 2023
  • Over the past 3 years, Health Holdings' median Liabilities and Shareholders Equity value was $16.7 million (recorded in 2021), while the average stood at $15.3 million.
  • Data for Health Holdings' Liabilities and Shareholders Equity shows a peak YoY increase of 22040.19% (in 2022) and a maximum YoY decrease of 22040.19% (in 2022) over the last 5 years.
  • Over the past 3 years, Health Holdings' Liabilities and Shareholders Equity (Quarter) stood at $8.0 million in 2021, then surged by 220.4% to $25.6 million in 2022, then tumbled by 91.89% to $2.1 million in 2023.
  • Its Liabilities and Shareholders Equity stands at $2.1 million for Q2 2023, versus $25.5 million for Q1 2023 and $25.6 million for Q4 2022.